Home
Home

AbbVie

The 5 Highest-Paying Dividend Stocks in Big Pharma

The 5 Highest-Paying Dividend Stocks in Big Pharma
Motley Fool

[video]AbbVie's New Crohn's Disease Drug Candidate

[video]AbbVie's New Crohn's Disease Drug Candidate
Motley Fool

AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy

AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
Yahoo

AbbVie's Latest Drug Deal Marks A Shift In The Celiac Disease Therapeutics Field

AbbVie's Latest Drug Deal Marks A Shift In The Celiac Disease Therapeutics Field
Seeking Alpha

AbbVie Investors, Watch This Management Change (video)

AbbVie Investors, Watch This Management Change (video)
Motley Fool

AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease

AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease
Yahoo/Reuters

Celgene: Apremilast For Psoriatic Arthritis Offers Upside

Celgene: Apremilast For Psoriatic Arthritis Offers Upside
Seeking Alpha

A Culture Change? AbbVie R&D Chief To Retire

A Culture Change? AbbVie R&D Chief To Retire
Pharmalot

AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease

AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
Yahoo

AbbVie, Pfizer's Zoetis deals ignite enormous leap in M&A value

AbbVie, Pfizer's Zoetis deals ignite enormous leap in M&A value
Fierce Pharma